Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-01-10 @ 7:05 AM
Study NCT ID:
NCT00649792
Status:
COMPLETED
Last Update Posted:
2012-02-28
First Post:
2008-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial
Sponsor:
Acorda Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2011-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-04
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-28
First Submit QC Date:
None
Study First Post Date:
2008-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-01-25
Results First Submit QC Date:
None
Results First Post Date:
2012-02-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-24
Last Update Post Date:
2012-02-28
Last Update Post Date Type:
ESTIMATED